- Esmirtazapine for the Treatment of Chronic Primary Insomnia: A Randomized Long-Term Safety Study in Elderly Outpatients
-
Ivgy-May N, Chang Q, Pong A, Winokur A
- KMID: 2504403
- J Sleep Med.
- 2020 Jun;17(1):19-30.
- doi: 10.13078/jsm.190032
Objectives: This 52-week, double-blind, randomized, Phase 3 study evaluated the long-term safety of esmirtazapine 1.5 mg and 3.0 mg in elderly outpatients (aged ≥65 years) with insomnia. Methods: Participants were randomized... -
- CITED
-
- Close
- SHARE
-
- Close
